12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Wednesday's pre-market session. Palisade Bio, Trevena, NeuBase Therapeutics, Journey Medical, Reshape Lifesciences, and NextGen Healthcare saw increases ranging from 14.74% to 65.3%. Meanwhile, Applied Molecular, RVL Pharmaceuticals, Axcella Health, DocGo, Cellectar Biosciences, and Addex Therapeutics experienced decreases ranging from 8.4% to 14.0%.
September 06, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Journey Medical's stock moved upwards by 16.3% to $2.46.
The upward movement in Journey Medical's stock price suggests positive investor sentiment, which could result in additional short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
NeuBase Therapeutics' shares increased by 18.26% to $1.36.
The increase in NeuBase Therapeutics' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
NextGen Healthcare's stock increased by 14.74% to $23.58.
The increase in NextGen Healthcare's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Palisade Bio's stock increased by 65.3% to $1.14 during Wednesday's pre-market session.
The significant increase in Palisade Bio's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences' shares rose 15.55% to $1.04.
The rise in Reshape Lifesciences' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Trevena's stock moved upwards by 23.41% to $1.08.
The upward movement in Trevena's stock price suggests positive investor sentiment, which could result in additional short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Addex Therapeutics' stock declined by 8.4% to $0.49.
The decline in Addex Therapeutics' stock price suggests negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Applied Molecular's shares decreased by 14.0% to $0.2 during Wednesday's pre-market session.
The significant decrease in Applied Molecular's share price suggests negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Axcella Health's shares fell 11.86% to $0.31.
The fall in Axcella Health's share price suggests negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Cellectar Biosciences' shares decreased by 8.47% to $2.27.
The decrease in Cellectar Biosciences' share price suggests negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
DocGo's shares declined by 9.62% to $7.38.
The decline in DocGo's share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
RVL Pharmaceuticals' shares decreased by 12.23% to $0.12.
The decrease in RVL Pharmaceuticals' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100